Revenue rises to 7.8m pounds in full year at Oxford Biomedica
27th Feb 2013 10:30
Gene-based biopharmaceutical company Oxford BioMedica has reported that revenue rose to 7.8m pounds in the full year 2012 from 7.7m pounds one year earlier. In its preliminary results for the year ending December 31st, the company stated that fundraising of £11.6m was completed in July 2012 with ne
Read moreOxford BioMedica halts trial due to poor recruitment
10th Oct 2012 10:25
Oxford BioMedica, a gene-based biopharmaceutical company, has made a strategic decision to close the US trial of its TroVax product on patients with progressive hormone refractory prostate cancer (HRPC) because recruitment has been much slower than originally anticipated. This is largely because co
Read moreSmall caps round-up: Brady, Oxford BioMedica, Densitron Tech
31st Aug 2012 12:48
Brady, a provider of trading, risk management and settlement solutions to the energy, metals and commodities sectors, has said that it is in a payment dispute over software with a customer that it signed in 2011. The firm said the customer has made payments to Brady totalling £288,000, but has "no
Read moreSmall Caps round-up: eXpansys, Oxford Biomedica, Dawson International
8th Aug 2012 10:15
eXpansys, the online electronics retailer has delivered a 33 per cent increase in turnover in the 12 months to the end of April. Total revenues for the year were 108.5m pounds, up 24pc on a like-for-like basis. Profits before tax were 4.3m pounds, a rise of 27pc on the prior year. The market had cle
Read moreSmall caps round-up: Quadrise, Software Radio, Motive Television ...
8th Jun 2012 11:36
Quadrise Fuels International, an emulsion fuels supplier, has admitted that during its first sea-borne assessment on a Mærsk container ship it was not possible to fully optimise engine performance, as the test configuration afforded limited scope for relevant 'in service' adjustments, but that the r
Read moreSmall caps round-up: Sportech, Silverdell, Oxford BioMedica
11th May 2012 12:35
Brooks Pierce, the Executive Director of Sportech, has resigned with immediate effect to 'pursue other business interests'. No replacement has yet been appointed, but the company was keen to announce that it had appointed an executive search business to 'seek suitable candidates to further augment S
Read moreSmall caps round-up: Omega Diagnostics, Oxford Biomedica, i-design ...
16th Apr 2012 10:58
The cash-point marketing company i-design said that revenues for the first half of its current financial year will be ahead of the same period of 2011. The group creates advertising solutions for banks and third parties through cash-point screens. A new contract with a Canadian bank has boosted turn
Read moreSmall caps round-up: Gable, Motive Television, Oxford BioMedica...
12th Mar 2012 07:47
Gable Holdings, a non-life insurance company, has reported that its performance in the second half, considering the traditional cyclicality of certain of our products, was in line with expectations. In the UK, the ATE product showed strong growth and which has continued into 2012, while construction
Read moreAnother director dealing for Dunelm; AZ Electronic tech officer makes sale
8th Mar 2012 15:35
Donna Wharton, wife of Nick Wharton, the Chief Executive of homewares firm Dunelm, has topped up her stake in the company with 9,500 shares. Wharton's purchase, which saw her buy the shares at 480.00p each for a total of £45,600, came just a day after Will Adderley, Executive Deputy Chairman, anno
Read moreSmall caps round-up: Arena, RedHot Media, Vp...
10th Feb 2012 11:09
Gene-based biopharmaceutical company Oxford Biomedia has announced that its Chief Financial Officer (CFO), Andrew Wood, has stepped down and will be replaced by Tim Watts with immediate effect. Watts has over 30 years' experience in leading multinational businesses and was most recently CFO at Archi
Read moreLondon close: Financials lead the way higher
15th Dec 2011 16:56
Footsie limped back above the 5,400 level in thin trade, with financial stocks leading the way. OLD MUTUAL SURGES AFTER DISPOSAL South African savings and insurance group Old Mutual was the best performing blue-chip after announcing that it is to sell its Nordic business Skandia AB for £2.1bn in
Read moreLondon midday: Old Mutual and miners provide a lift
15th Dec 2011 11:46
The Footsie held on to gains by lunchtime, breaking through the 5,400 level, with strong gains for Old Mutual and the miners lifted London's blue chip index 0.6% higher. In domestic news, the volume of UK retail sales fell by 0.4% in November compared to the month before, according to the latest da
Read moreOxford Biomedica plummets on test results
15th Dec 2011 10:11
Shares in Oxford Biomedica slumped to a 52-week low after a disappointing set of test results for ProSavin, its treatment for Parkinson's disease. In clinical trials it appears that while higher doses of the drug initially improved symptoms for patients, after six months the benefits of higher dosa
Read moreOxford BioMedica hit by impairment charge
31st Aug 2011 08:07
Pre-tax losses at gene-based biopharmaceutical firm Oxford BioMedica widened after it took a £3.1m impairment charge when it wrote down the value of its Hi8 MEL melanoma vaccine when it failed to find a commercial partner for the product. The group posted a pre-tax loss of just under £9m for the si
Read moreTechMARK movers: Sinclair extends agreement to India
21st Mar 2011 12:43
Dermatological treatments supplier Sinclair Pharma has agreed an extension of its partnership with Invida Group to include India. Invida has exclusivity for Sinclair's dermatology and wound care brands in 12 Asia Pacific countries. The two companies are preparing the initial launches in these mar
Read more